InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Alpern Robert J. Officer active across 3 companies, notably AbbVie Inc.. In total, 6 reports have been recorded. The latest transaction was disclosed on 6 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
01,421 shares0
Common Stock, $0.01 par value
SEC:0001179110-22-002924:0·
01,602 shares0
Common shares without par value
SEC:0001415889-22-004546:0·
016,403 shares0
Common Stock
SEC:0001595585-21-000076:0·
016,403 shares0
Common Stock
SEC:0001595585-21-000076·
€161,5181,681 shares@ €96.08450.0000% mcap100.0% of flow
Common Stock, $0.01 par value
SEC:0001179110-21-005197·
€161,5181,681 shares@ €96.08450.0000% mcap50.0% of flow
Common Stock, $0.01 par value
SEC:0001179110-21-005197:0·
6 of 6 declarations
About Alpern Robert J
Robert J Alpern is a director at AbbVie Inc., and also holds positions at Tricida, Inc. and Abbott Laboratories.
